Portfolio

The Crystal Palace
Being published in late 2021

John L. Gore, Marguerite du Plessis, Jingbin Zhang, Darlene Dai, Darby J.S. Thompson, Lawrence Karsh, Brian Lane, Michael Franks, David Y.T. Chen, Fernando J. Bianco Jr., Gordon Brown, William Clark, Adam S. Kibel, Hyung Kim, William Lowrance, Murugesan Manoharan, Paul Maroni, Scott Perrapato, Paul Sieber, , Edouard J. Trabulsi, Robert Waterhouse, Daniel E. Spratt, Elai Davicioni, Yair Lotan, Daniel W. Lin. Clinical Utility of a Genomic Classifier in Men Undergoing Radical Prostatectomy: The PRO-IMPACT Trial. Practical Radiation Oncology. 2019

Radtke J.P., Takhar M., Bonekamp D., Kesch C., Erho N., du Plessis M., Buerki C., Ong K., Davicioni E., Hohenfellner M., Ha- daschik B.A. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit. European Urology Focus. 2017. pii: S2405-4569(17)30010-X. doi: 10.1016/j.euf.2017.01.005.

Matthew R. Cooperberg, Nicholas Erho, June M. Chan, Felix Y. Feng, Nick Fishbane, Shuang G. Zhao, Jeffry P. Simko, Janet E. Cowan, Jonathan Lehrer, Mohammed Alshalalfa, Tyler Kolisnik, Jijumon Chelliserry, Jennifer Margrave, Maria Aranes, Marguerite du Plessis, Christine Buerki, Imelda Tenggara, Elai Davicioni and Peter R. Carroll.  The diverse genomic landscape of low−risk prostate cancer. European Urology. 2018 (Oct):74(4): 444

Gore J.L., du Plessis M., Santiago-Jimenez M., Yousefi K., Thompson D.J.S., Karsh L., Lane B., Franks M., Chen D.Y.T., Bandyk M., Bianco F.J., Brown G., Clark W., Kibel A.S., Kim H., Lowrance W., Manoharan M., Maroni P., Perrapato S., Sieber P., Trabulsi E.J., Waterhouse R., Davicioni E., Lotan Y., Lin D.W. Decipher Test Impacts Decision-Making among Patients Considering Adjuvant and Salvage Treatment following Radical Prostatectomy: Interim Results from the Multicenter Prospective PRO-IMPACT Study. Cancer. 2017 Aug;123(15):2850-2859 doi: 10.1002/cncr.30665.

Spratt D.E., Zhang J., Santiago-Jiménez M., Dess R.T., Davis J.W., Den R.B., Dicker A.P., Kane C.J., Pollack A., Stoyanova R., Abdol- lah F., Ross A.E., Cole A., Uchio E., Randall J.M., Nguyen H., Zhao S.G., Mehra R., Glass A.G., Lam L.L.C., Chelliserry J., du Plessis M., Choeurng V., Aranes M., Kolisnik T., Margrave J., Alter J., Jordan J., Buerki C., Yousefi K., Haddad Z., Davicioni E., Trabulsi E.J., Loeb S., Tewari A., Carroll P.C., Weinmann S., Schaeffer E.M., Klein E.A., Karnes R.J., Feng F.Y., Nguyen P.L. Development and Vali- dation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. Journal of Clinical Oncology. 2018 Feb 20;36(6):581-590. doi: 10.1200/JCO.2017.74.2940PRO-IMPACT Study. Cancer. 2017 

nature